-
January 19, 2007 Lupin and Aspen decide not to pursue their MOU
-
January 17, 2007 Lupin FY 2006-07 Q3 Net Profit up by 27% at Rs.560 mn
-
January 2, 2007 Lupin gets tentative US FDA approval for Sertraline
-
December 27, 2006 Lupin and Cornerstone End Development Agreement
-
December 25, 2006 Lupin’s US Subsidiary and Chester Valley Pharmaceuticals decide to end promotion agreement
-
December 19, 2006 Lupin gets tentative US FDA approval for Trandolapril
-
December 7, 2006 Lupin gets DCGI approval to conduct Phase III clinical trials for Migraine NCE
-
October 19, 2006 Lupin FY 2006-07 Q2 Net Profit up by 29% at Rs.583 mn
-
September 30, 2006 Lupin and Dafra decide not to pursue their MoU
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications